New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
08:02 EDTGTCB
theflyonthewall.com: GTC Biotherapeutics receives extension from Nasdaq
GTC Biotherapeutics has received from a NASDAQ Hearings Panel an extension to March 16, 2010 to regain compliance with the market value of listed securities requirement for continued listing on The NASDAQ Capital Market, as specified by NASDAQ Listing Rule 5550(b)(2). The Company’s common stock will continue to be listed on The NASDAQ Capital Market during the extension. GTC can satisfy the terms of the Panel’s decision by demonstrating a market value of listed securities of at least $35M for ten consecutive trading days prior to the end of the extension period. :theflyonthewall.com



News For GTCB From The Last 14 Days
Check below for free stories on GTCB the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2010
08:08 EDTGTCB
theflyonthewall.com: GTC Biotherapeutics provides Recombinant FVIIa regulatory update
GTC Biotherapeutics and its strategic partner LFB Biotechnologies announced that, following discussions with the FDA, they are moving forward with their plans to file an IND for a phase I study for the transgenically derived recombinant human Factor VIIa being developed in their joint venture. This rhFVIIa is being developed for the treatment of hemophilia patients who have developed antibodies to Factor VIII or Factor IX. GTC and LFB plan to initiate the phase I study in the second quarter of 2010. :theflyonthewall.com